| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |